IMV Inc. (IMVIF)
USD 0.0
(-50.0%)
USD 0.0
(-50.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2022 | 37.93 Million USD | 32.91% |
| 2021 | 28.54 Million USD | 87.81% |
| 2020 | 15.19 Million CAD | 23.27% |
| 2019 | 12.32 Million CAD | -9.52% |
| 2018 | 13.62 Million USD | 59.7% |
| 2017 | 8.53 Million USD | 40.93% |
| 2016 | 6.05 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2022 Q3 | 38.31 Million USD | 0.45% |
| 2022 FY | 37.93 Million USD | 32.91% |
| 2022 Q2 | 38.13 Million USD | 31.14% |
| 2022 Q4 | 37.93 Million USD | -0.99% |
| 2022 Q1 | 29.08 Million USD | 1.9% |
| 2021 Q3 | 16.76 Million USD | 0.0% |
| 2021 Q4 | 28.54 Million USD | 70.2% |
| 2021 FY | 28.54 Million USD | 87.81% |
| 2020 FY | 15.19 Million CAD | 23.27% |
| 2019 FY | 12.32 Million CAD | -9.52% |
| 2018 FY | 13.62 Million USD | 59.7% |
| 2017 FY | 8.53 Million USD | 40.93% |
| 2016 FY | 6.05 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 27.43 Thousand USD | -138174.319% |
| Arch Therapeutics, Inc. | 9.46 Million USD | -300.73% |
| Evofem Biosciences, Inc. | 72.47 Million USD | 47.658% |
| Nascent Biotech, Inc. | 808.79 Thousand USD | -4590.044% |
| Rebus Holdings, Inc. | 5.24 Million USD | -623.632% |
| Santhera Pharmaceuticals Holding AG | 59.01 Million USD | 35.722% |
| Qrons Inc. | 1.48 Million USD | -2448.026% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 1.22 Million USD | -2993.491% |
| Northwest Biotherapeutics, Inc. | 74.92 Million USD | 49.369% |
| ProtoKinetix, Incorporated | 44.69 Thousand USD | -84768.431% |
| Skye Bioscience, Inc. | 14.07 Million USD | -169.558% |
| Eiger BioPharmaceuticals, Inc. | 53.3 Million USD | 28.838% |
| Nanobac Pharmaceuticals, Incorporated | 9.58 Million USD | -295.875% |
| Institute of Biomedical Research Corp. | 421.56 Thousand USD | -8898.025% |
| SQZ Biotechnologies Company | 50.03 Million USD | 24.194% |
| Intellipharmaceutics International Inc. | 12 Million USD | -215.876% |
| Propanc Biopharma, Inc. | 3.85 Million USD | -884.903% |
| Mesoblast Limited | 188.44 Million USD | 79.871% |
| Marizyme, Inc. | 26.67 Million USD | -42.2% |
| Genus plc | 485 Million USD | 92.179% |
| VioQuest Pharmaceuticals, Inc. | 5.84 Million USD | -549.243% |
| Pharming Group N.V. | 244.07 Million USD | 84.458% |
| Therapeutic Solutions International, Inc. | 2.01 Million USD | -1787.082% |
| CNBX Pharmaceuticals Inc. | 2.51 Million USD | -1407.466% |
| Nymox Pharmaceutical Corporation | 3.8 Million USD | -898.231% |
| ContraFect Corporation | 32.53 Million USD | -16.605% |
| PsyBio Therapeutics Corp. | 1.98 Million USD | -1814.533% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 3.82 Million USD | -891.021% |
| AXIM Biotechnologies, Inc. | 11.77 Million USD | -222.059% |
| MultiCell Technologies, Inc. | 1617.67 USD | -2344803.101% |
| ONE Bio Corp. | 27.49 Million USD | -37.958% |
| Accustem Sciences Inc. | 1.07 Million USD | -3414.772% |
| RVL Pharmaceuticals plc | 77.41 Million USD | 51.002% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 2.11 Million USD | -1693.454% |
| Q BioMed Inc. | 8.13 Million USD | -366.409% |
| Emmaus Life Sciences, Inc. | 82.93 Million USD | 54.262% |
| Mosaic ImmunoEngineering Inc. | 5.14 Million USD | -637.127% |
| Biomind Labs Inc. | 1.49 Million USD | -2431.195% |
| American Oriental Bioengineering, Inc. | 118.72 Million USD | 68.049% |
| Provectus Biopharmaceuticals, Inc. | 9.04 Million USD | -319.509% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 18.4 Million USD | -106.118% |
| GlobeStar Therapeutics Corporation | 1.43 Million USD | -2545.5% |
| THC Farmaceuticals, Inc. | 142.09 Thousand USD | -26595.376% |
| Acro Biomedical Co., Ltd. | 201.11 Thousand USD | -18761.152% |
| Curative Biotechnology, Inc. | 5.74 Million USD | -560.181% |
| GB Sciences, Inc. | 5.41 Million USD | -600.183% |
| Alpha Cognition Inc. | 7.16 Million USD | -429.435% |
| HST Global, Inc. | 593.59 Thousand USD | -6290.371% |
| CSL Limited | 18.62 Billion USD | 99.796% |
| Wesana Health Holdings Inc. | 1.25 Million USD | -2912.469% |
| Halberd Corporation | 728.71 Thousand USD | -5105.408% |
| Enzolytics Inc. | 365.26 Million USD | 89.615% |
| Agentix Corp. | 2.51 Million USD | -1410.933% |
| Resverlogix Corp. | 67.39 Million USD | 43.717% |
| Nuo Therapeutics, Inc. | 838.73 Thousand USD | -4422.636% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 444.95 Million USD | 91.475% |
| Enzon Pharmaceuticals, Inc. | 1.71 Million USD | -2113.115% |
| Endonovo Therapeutics, Inc. | 24.74 Million USD | -53.288% |
| RespireRx Pharmaceuticals Inc. | 11.9 Million USD | -218.68% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.66 Million USD | -934.955% |
| AVAX Technologies, Inc. | 3.99 Million USD | -849.805% |
| Zenith Capital Corp. | 27.56 Thousand USD | -137492.201% |
| Genscript Biotech Corporation | 1.32 Billion USD | 97.139% |
| Ember Therapeutics, Inc. | 238.65 Thousand USD | -15794.472% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 3.73 Million USD | -915.792% |
| WPD Pharmaceuticals Inc. | 680.83 Thousand USD | -5471.519% |
| Cotinga Pharmaceuticals Inc. | 2.71 Million USD | -1298.887% |
| Kadimastem Ltd | 3.5 Million USD | -982.289% |
| Helix BioMedix, Inc. | 66.92 Thousand USD | -56576.17% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 50.26 Million USD | 24.533% |
| BioStem Technologies, Inc. | 15.9 Million USD | -138.501% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 464.69 Thousand USD | -8062.874% |
| LadRx Corporation | 2.2 Million USD | -1623.804% |
| Cell Source, Inc. | 15.8 Million USD | -139.979% |
| Regen BioPharma, Inc. | 5.45 Million USD | -595.043% |
| Regen BioPharma, Inc. | 5.45 Million USD | -595.043% |
| NovAccess Global Inc. | 7.86 Million USD | -382.561% |
| Affymax, Inc. | 8.87 Million USD | -327.604% |
| Itoco Inc. | 1.65 Million USD | -2194.575% |
| Rasna Therapeutics, Inc. | 2.05 Million USD | -1748.969% |
| Pathfinder Cell Therapy, Inc. | 6.04 Million USD | -527.092% |
| Mobile Lads Corp. | 1.31 Million USD | -2787.924% |
| CytoDyn Inc. | 127.89 Million USD | 70.34% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 41.79 Thousand USD | -90650.482% |
| NanoSphere Health Sciences Inc. | 1.56 Million USD | -2321.69% |
| Alseres Pharmaceuticals, Inc. | 11.04 Million USD | -243.43% |
| SYBLEU INC | 681.41 Thousand USD | -5466.785% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 6.1 Million USD | -521.655% |
| International Stem Cell Corporation | 5.27 Million USD | -618.833% |
| Bioxytran, Inc. | 3.24 Million USD | -1067.342% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 625.8 Thousand USD | -5961.401% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 4.61 Million USD | -721.567% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 40.99 Million USD | 7.472% |
| Adhera Therapeutics, Inc. | 22.26 Million USD | -70.37% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 2.02 Million USD | -1772.866% |
| Innovation Pharmaceuticals Inc. | 5.47 Million USD | -592.457% |
| Neutra Corp. | 973.52 Thousand USD | -3796.422% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -30.735% |
| PureTech Health plc | 125.58 Million USD | 69.795% |
| Coeptis Therapeutics, Inc. | 3.75 Million USD | -909.623% |
| IXICO plc | 1.9 Million USD | -1896.156% |
| IntelGenx Technologies Corp. | 20.52 Million USD | -84.777% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 63.288% |
| CSL Limited | 18.62 Billion USD | 99.796% |
| Cellectis S.A. | 249.36 Million USD | 84.789% |